Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans

J Biomol Struct Dyn. 2021 Aug;39(12):4563-4565. doi: 10.1080/07391102.2020.1776640. Epub 2020 Jun 12.

Authors

Nikhil Kirtipal¹, Shiv Bharadwaj²

Affiliations

¹ Department of Science, Modern Institute of Technology, Dhalwala, Rishikesh, Uttarakhand, India.
² Department of Biotechnology, Institute of Biotechnology, College of Life and Applied Sciences, Yeungnam University, Gyeongsan, Gyeongbuk, Republic of Korea.

PMID: 32490733
DOI: 10.1080/07391102.2020.1776640

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Humans
Interleukin-6* / genetics
SARS-CoV-2

Substances

Interleukin-6